“Efficacy of Generic Bortezomib Used As a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma”. Innovative Journal of Medical and Health Sciences, vol. 9, no. 1, Feb. 2019, pp. 247-51, https://doi.org/10.15520/ijmhs.v9i1.2431.